Drug intelligence / Profile preview

Lymdiaral

Development stage
Unknown
Lead developer
Pascoe Naturmedizin
Administration
Intradermal, Parenteral
01

Overview

Lymdiaral (specifically Lymdiaral Injektopas) is a multi-component homeopathic and bioregulatory injectable preparation developed by NAMED S.r.l. in partnership with Pascoe. It is formulated as a complex remedy containing various homeopathic and phytotherapeutic ingredients, including *Taraxacum*, *Calendula*, *Arsenicum album*, and *Echinacea*, among others. The preparation is designed to support the lymphatic system by stimulating toxin drainage, inhibiting inflammation, and restoring hepatic function. It is primarily used for conditions such as lymphatism, chronic-recurrent inflammatory states, and edemas (post-traumatic, post-surgical, or radiation-related). In clinical research, it has been evaluated in Phase 4 pilot studies for the treatment of chronic venous-lymphatic insufficiency associated with panniculopathy-edema-fibrosclerotic (PEFS) via district intradermotherapy.

Brand names
LymdiaralLymdiaral InjektopasPASCOE LYMDIARAL Injektopas

Beyond the preview

Go deeper on Lymdiaral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymdiaral.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call